May 21, 2020
US Dermatophytic Onychomycosis Drug Forecast and Market Analysis 2020-2028, Featuring Actavis, Allergan and Topica Pharmaceuticals
May 06, 2020
Bausch Health And Alfasigma Announce Resolution Of XIFAXAN® Intellectual Property Litigation
Jan 30, 2020
Aprecia Appoints Amol Matharu Chief Scientific Officer
Jan 06, 2020
Warner Chilcott and Watson Resolve Antitrust Class Action Litigation with Direct and Indirect Purchasers of Loestrin 24 Fe and Minastrin 24 Fe
Dec 19, 2019
Amgen And Allergan Submit Biologics License Application For ABP 798, Biosimilar Candidate To Rituxan® (rituximab), To U.S. Food And Drug Administration
Oct 01, 2019
Bausch Health Files Lawsuit Against Sandoz For Infringement Of Patents Protecting XIFAXAN® 550 mg Tablets
Jul 24, 2019
Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders
May 02, 2019
Orexo: Interim Report Q1 2019
Mar 29, 2019
District Court of Delaware Rules that Actavis does not Infringe with their Suboxone® and Subutex® Generics
Feb 19, 2019
United States Generic Drug Markets, 2011-2018 & 2019-2024 - Patent Expiry of Blockbuster Drugs & Significant Price Differential between Generics and Innovator Drugs
Jan 11, 2019
Actavis Infringes Orexo's Long Term Zubsolv® U.S. Patent ´330
Sep 12, 2018
Bausch Health Announces Resolution Of XIFAXAN® Intellectual Property Litigation
Sep 10, 2018
Orexo Wins Appeal Against Actavis on Zubsolv Patent in the US
Aug 13, 2018
Global Intrauterine Devices Market Research Report 2018 - Forecast to 2023
Aug 08, 2018
Allergan Appoints Neurobiology Expert Michael E. Greenberg, PhD to its Board of Directors as Part of Active Board Refreshment Process
Jun 20, 2018
Amneal Announces Patent Litigation Settlement Agreement with Actavis Concerning Rytary®
Mar 23, 2018
Amgen And Allergan Receive Positive CHMP Opinion For ABP 980 (Biosimilar Herceptin®) For The Treatment Of Three Types Of Cancer
Feb 15, 2018
United Therapeutics Announces Settlement Of Patent Litigation With Actavis Laboratories FL, Inc. Relating To Orenitram
Feb 08, 2018
Indivior Files Complaints Asserting New SUBOXONE® Film Patent Against ANDA-filers
Feb 06, 2018
Andrew S. Boyer Joins Amneal Pharmaceuticals as Executive Vice President, Commercial Operations